KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Work In Process (2016 - 2025)

Pacific Biosciences Of California has reported Work In Process over the past 15 years, most recently at $27.1 million for Q4 2025.

  • Quarterly results put Work In Process at $27.1 million for Q4 2025, up 22.01% from a year ago — trailing twelve months through Dec 2025 was $27.1 million (up 22.01% YoY), and the annual figure for FY2025 was $27.1 million, up 22.01%.
  • Work In Process for Q4 2025 was $27.1 million at Pacific Biosciences Of California, up from $25.2 million in the prior quarter.
  • Over the last five years, Work In Process for PACB hit a ceiling of $27.9 million in Q3 2023 and a floor of $6.9 million in Q1 2021.
  • Median Work In Process over the past 5 years was $21.7 million (2023), compared with a mean of $19.3 million.
  • Biggest five-year swings in Work In Process: skyrocketed 135.87% in 2023 and later crashed 34.4% in 2024.
  • Pacific Biosciences Of California's Work In Process stood at $8.6 million in 2021, then soared by 63.3% to $14.1 million in 2022, then soared by 96.65% to $27.7 million in 2023, then fell by 19.82% to $22.2 million in 2024, then grew by 22.01% to $27.1 million in 2025.
  • The last three reported values for Work In Process were $27.1 million (Q4 2025), $25.2 million (Q3 2025), and $26.9 million (Q2 2025) per Business Quant data.